CFO Jane Henderson Executes Planned 2,700‑Share Sale at $70.45 – Insider Liquidity, Not Panic, in Apogee Therapeutics Flash
Insider CFO sells 2,700 Apogee shares at $70.45/stock, showing disciplined Rule 10b5‑1 trades, not panic—investors can gauge future pipeline upside.
3 minutes to read